$ITRM

Company: Iterum Therapeutics plc Symbol: ITRM Description: They are a pharmaceutical company dedicated to developing and commercializing sulopenem to be potentially the first and only oral and intravenous (IV) branded penem available globally. Trade Date: 5/25 Shares: 5.33 million Price Range: $14.00-$16.00 Underwriter(s): Leerink Partners, RBC Capital Partners Co-Manager(s): Guggenheim Securities, Needham & Co. Terms[…]